Cargando…

Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model

Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve metabolic health and extend the life span of mice and humans. However, most studies conducted thus far have focused on the preventive effects of LPDs on metabolic syndromes. To test the therapeutic potential of LPD,...

Descripción completa

Detalles Bibliográficos
Autores principales: Munoz, Marcos, Zamudio, Alexa, McCann, Maximilian, Gil, Victoria, Xu, Pingwen, Liew, Chong Wee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081364/
https://www.ncbi.nlm.nih.gov/pubmed/37034803
http://dx.doi.org/10.21203/rs.3.rs-2701883/v1
_version_ 1785021106889949184
author Munoz, Marcos
Zamudio, Alexa
McCann, Maximilian
Gil, Victoria
Xu, Pingwen
Liew, Chong Wee
author_facet Munoz, Marcos
Zamudio, Alexa
McCann, Maximilian
Gil, Victoria
Xu, Pingwen
Liew, Chong Wee
author_sort Munoz, Marcos
collection PubMed
description Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve metabolic health and extend the life span of mice and humans. However, most studies conducted thus far have focused on the preventive effects of LPDs on metabolic syndromes. To test the therapeutic potential of LPD, we treated a lipodystrophy mouse model IR(FKO) (adipose-specific insulin receptor knockout) in this study. We have previously shown that IR(FKO) mice have profound insulin resistance, hyperglycemia, and whitenng of interscapular brown adipose tissue (BAT), closely mimicking the phenotypes in lipoatrophic diabetic patients. Here, we demonstrate that 14-day of LPD (5.1% kcal from protein) feeding is sufficient to reduce postprandial blood glucose, improve insulin resistance, and normalize glucose tolerance in the IR(FKO) mice. This profound metabolic improvement is associated with BAT activation and increase in whole body energy expenditure. To confirm, we showed that surgical denervation of BAT attenuated the beneficial metabolic effects of LPD feeding in IR(FKO) mice, including the ‘browning’ effects on BAT and the glucose-ameliorating results. However, BAT denervation failed to affect the body weight-lowering effects of LPD. Together, our results imply a therapeutic potential to use LPD for the treatment of lipoatrophic diabetes.
format Online
Article
Text
id pubmed-10081364
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-100813642023-04-08 Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model Munoz, Marcos Zamudio, Alexa McCann, Maximilian Gil, Victoria Xu, Pingwen Liew, Chong Wee Res Sq Article Long-term ad libitum dietary restrictions, such as low-protein diets (LPDs), improve metabolic health and extend the life span of mice and humans. However, most studies conducted thus far have focused on the preventive effects of LPDs on metabolic syndromes. To test the therapeutic potential of LPD, we treated a lipodystrophy mouse model IR(FKO) (adipose-specific insulin receptor knockout) in this study. We have previously shown that IR(FKO) mice have profound insulin resistance, hyperglycemia, and whitenng of interscapular brown adipose tissue (BAT), closely mimicking the phenotypes in lipoatrophic diabetic patients. Here, we demonstrate that 14-day of LPD (5.1% kcal from protein) feeding is sufficient to reduce postprandial blood glucose, improve insulin resistance, and normalize glucose tolerance in the IR(FKO) mice. This profound metabolic improvement is associated with BAT activation and increase in whole body energy expenditure. To confirm, we showed that surgical denervation of BAT attenuated the beneficial metabolic effects of LPD feeding in IR(FKO) mice, including the ‘browning’ effects on BAT and the glucose-ameliorating results. However, BAT denervation failed to affect the body weight-lowering effects of LPD. Together, our results imply a therapeutic potential to use LPD for the treatment of lipoatrophic diabetes. American Journal Experts 2023-03-31 /pmc/articles/PMC10081364/ /pubmed/37034803 http://dx.doi.org/10.21203/rs.3.rs-2701883/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Article
Munoz, Marcos
Zamudio, Alexa
McCann, Maximilian
Gil, Victoria
Xu, Pingwen
Liew, Chong Wee
Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
title Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
title_full Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
title_fullStr Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
title_full_unstemmed Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
title_short Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
title_sort activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081364/
https://www.ncbi.nlm.nih.gov/pubmed/37034803
http://dx.doi.org/10.21203/rs.3.rs-2701883/v1
work_keys_str_mv AT munozmarcos activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel
AT zamudioalexa activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel
AT mccannmaximilian activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel
AT gilvictoria activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel
AT xupingwen activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel
AT liewchongwee activationofbrownadiposetissuebyalowproteindietameliorateshyperglycemiainadiabeticlipodystrophymousemodel